Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunology
Biotech
Sanofi pays Regeneron $1B for 4 early-stage assets to ignite R&D
The deal, which features $7 billion in milestones, tees the longstanding partners up to try to replicate Dupixent’s success.
Nick Paul Taylor
Oct 1, 2026 4:24am
Enanta sheds staffers as key readouts loom
Sep 29, 2026 1:30pm
Tolerance continues thymus-focused deals with $560M Tanabe pact
Sep 28, 2026 8:59am
Roche signs $1B Dualitas deal to collab on bispecific screening
Sep 17, 2026 8:07am
Electra seeks $342M IPO to power inflammatory drug’s ph. 3 push
Sep 14, 2026 8:52am
Schrödinger births new immunology focused biotech, Tectora
Sep 9, 2026 7:00am
